New and emerging treatments for ulcerative colitis: a focus on vedolizumab

Ulcerative colitis (UC) is the most common form of chronic inflammatory bowel disease and lacks a curative pharmacological treatment. Traditional therapies, which include 5-aminosalicylates, corticosteroids and immunosuppressants, aim to induce and maintain remission. Biological therapy with anti-tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gledhill, Tamsin, Bodger, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666591/
https://www.ncbi.nlm.nih.gov/pubmed/23723689
http://dx.doi.org/10.2147/BTT.S30416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666591/
https://www.ncbi.nlm.nih.gov/pubmed/23723689
http://dx.doi.org/10.2147/BTT.S30416

Ejemplares similares